Medical Oncology Partners (Tables)

9 Months Ended

Sep. 30, 2022

Medical Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of MOP:

MOP Condensed Consolidated Income Statement Information

	Nine Months Ended
	September 30,
	2022			2021
Patient revenue	$	1,488,000		$	1,601,000
Net loss	$	(588,000	)	$	(280,000	)
USNC’s equity in loss in MOP	$	(211,000	)	$	(100,000	)

	Three Months Ended
	September 30,
	2022			2021
Patient revenue	$	439,000		$	532,000
Net loss	$	(340,000	)	$	(185,000	)
USNC’s equity in loss of MOP	$	(121,000	)	$	(66,000	)

MOP Condensed Consolidated Balance Sheet Information

	September 30,			December 31,
	2022			2021
Current assets	$	136,000		$	201,000
Noncurrent assets		162,000			384,000
Total assets	$	298,000		$	585,000
Current liabilities	$	3,449,000		$	3,109,000
Noncurrent liabilities		50,000			92,000
Deficit		(3,201,000	)		(2,616,000	)
Total liabilities and deficit	$	298,000		$	585,000